FOXO BIOSCIENCE
DEAD

Serial Number

88832781

Owner

FOXO TECHNOLOGIES INC.

Attorney

Heather Kliebenstein

Filing Date

Mar 12, 2020

Add to watchlist:

No watchlists yet
View on USPTO

FOXO BIOSCIENCE Trademark

Serial Number: 88832781

FOXO BIOSCIENCE is a trademark filed by FOXO TECHNOLOGIES INC. on March 12, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services). The application is currently no longer active.

Owner Contact Info

FOXO TECHNOLOGIES INC. (12 trademarks)

MINNEAPOLIS, MN 55402

Entity Type: 03

FOXO BIOSCIENCE LLC (11 trademarks)

MINNEAPOLIS, MN 55402

Entity Type: 16

Trademark Details

Filing Date

March 12, 2020

Registration Date

Not Registered

Published for Opposition

May 2, 2023

Goods & Services

Providing an online resource center, namely, online non-downloadable articles and papers in the fields of longevity, aging, genetic and epigenetic testing and genotyping and genomic technologies; Providing a website featuring online non-downloadable publications in the nature of articles, journals, brochures, leaflets, guides and manuals in the fields of longevity, aging, genetic and epigenetic testing and genotyping and genomic technologies; Providing an online publication in the nature of an non-downloadable interactive encyclopedia in the fields of longevity, aging, genetic and epigenetic testing and genotyping and genomic technologies; Educational services, namely, providing seminars, workshops, customer trainings and tutorials in the fields of, and for use in the fields of, health and aging tips and strategies, disease prevention, nucleic acid sequencing, genetics, epigenetics, genotyping, genomics, metagenomics, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, population research, and actuarial services; Providing non-downloadable electronic newsletters and online non-downloadable electronic newsletters delivered via email for use in the fields of health and aging tips and strategies, disease prevention, nucleic acid sequencing, genetics, epigenetics, genotyping, genomics, metagenomics, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, population research, and actuarial services; Educational services, namely, providing training of clinicians, scientists, researchers and medical professionals in the use of scientific equipment, instruments and techniques, namely, genomic sequencers, molecular diagnostic technologies, microarray technologies, DNA extraction, bioinformatics, and automated laboratory apparatus; Providing facilities for training in operation and use of scientific equipment, instruments and techniques, namely, genomic sequencers, molecular diagnostic technologies, microarray technologies, DNA extraction, bioinformatics, and automated laboratory apparatus

Computer systems, namely, computer hardware, downloadable computer software, and downloadable electronic data files for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes, and excluding software that facilitates communication, collaboration, networking and the sharing of medical information and imaging between medical professionals with other medical professionals and medical service providers; Downloadable computer software for data collection, management, and analysis of molecular health, genetic and epigenetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes, excluding software that facilitates communication, collaboration, networking and the sharing of medical information and imaging between medical professionals with other medical professionals and medical service providers

Medical diagnostic reagents; Clinical medical diagnostic reagents

Insurance information and consultancy; Insurance services, namely, insurance eligibility review and verification and consultation in the life insurance industry; Insurance services, namely, underwriting, issuing and administration of life insurance; Insurance agency and brokerage

Epigenetic test kits comprising reagents for testing and analyzing saliva for non-medical purposes; Reagent kits and beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical diagnostic purposes

Online social networking services in the field of genetics and epigenetics

Medical testing for screening, diagnostic or prognostic purposes; DNA sequencing, screening, and analysis services for medical diagnostic purposes; Nucleic acid sequencing, screening, and analysis services for medical diagnostic purposes; Genomic sequencing, screening, and analysis services for medical diagnostic purposes; Genetic and epigenetic analysis and reporting services for medical diagnostic purposes; Medical diagnostic testing, monitoring and reporting services in the field of infectious disease identification and surveillance

Providing scientific analysis in the field of personal epigenetics; Reporting of consumer authorized molecular health, aging and longevity results direct to the consumer for non-medical purposes, namely, epigenetic testing, analysis and evaluation of saliva; Testing, analysis and evaluation of DNA for epigenetic patterns associated with alcohol and tobacco use and other traits about an individual for non-medical purposes; Providing an interactive website featuring technology that allows users to enter, access, track, monitor and generate information and reports in the fields of personal epigenetics, health and wellness

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 22, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 22, 2024 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 19, 2023 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Aug 10, 2023 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Jun 1, 2023 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 2, 2023 NPUB
PUBLISHED FOR OPPOSITION
May 2, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 12, 2023 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 30, 2023 PREV
ASSIGNED TO LIE
Mar 23, 2023 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 9, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 8, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 8, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 8, 2023 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 16, 2022 GNFN
FINAL REFUSAL E-MAILED
Dec 16, 2022 GNFR
FINAL REFUSAL WRITTEN
Dec 16, 2022 CNFR
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Nov 18, 2022 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Nov 18, 2022 PARI
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 28, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 27, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 27, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 27, 2022 GNRN
NON-FINAL ACTION E-MAILED
Apr 27, 2022 GNRT
NON-FINAL ACTION WRITTEN
Apr 27, 2022 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 20, 2022 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 20, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 31, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 30, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 30, 2022 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 17, 2021 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 17, 2021 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 17, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 17, 2021 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 30, 2021 GNRN
NON-FINAL ACTION E-MAILED
Sep 30, 2021 GNRT
NON-FINAL ACTION WRITTEN
Sep 30, 2021 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 30, 2021 RCCK
ASSIGNED TO EXAMINER
Aug 12, 2021 DOCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 2, 2021 RCCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 9, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 9, 2021 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jul 9, 2021 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 9, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 9, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 9, 2021 COAR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 19, 2021 ASGN
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 20, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 20, 2020 GNSL
SUSPENSION LETTER WRITTEN
Oct 20, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 29, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 28, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 28, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 26, 2020 GNRN
NON-FINAL ACTION E-MAILED
Mar 26, 2020 GNRT
NON-FINAL ACTION WRITTEN
Mar 26, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 21, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 19, 2020 NWOS
NEW APPLICATION ENTERED
Mar 16, 2020 NWAP